The University of Iowa was awarded a $2,935,084 federal Project Grant (R61AT012275) from the National Institute of Neurological Disorders and Stroke (CFDA Program 93.279 - Drug Use and Addiction Research Programs) to develop diagnostic and prognostic ultrasound imaging biomarkers for plantar heel pain, a common musculoskeletal condition. The project aims to use novel imaging techniques to create a diagnostic biosignature to objectively detect abnormal myofascial tissue, and to develop predictive and response biosignatures to guide targeted treatments. As part of this effort, the University of Iowa is collaborating with the Rochester Institute of Technology on a $524,501 sub-award to specifically focus on developing diagnostic imaging biomarkers to differentiate individuals with plantar fasciitis from other foot pain conditions and healthy controls. These research activities are expected to enhance the management of musculoskeletal pain by providing better tools for detecting and treating abnormal myofascial tissue.
Generated 3/4/25, 5:44 AM